机译:IDH1 / 2-突变反复性胶质瘤患者的5-氮己啶
Paris Saclay Univ Pharm Clin Serv Gustave Roussy Canc Campus Villejuif France;
Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Paris France;
Paris Saclay Univ Pharm Clin Serv Gustave Roussy Canc Campus Villejuif France;
Sorbonne Univ Inst Brain & Spinal Cord Dept Neurosurg Univ Hosp Pitie Salpetriere Charles Foix Neuropat Paris France;
Univ Paris Saclay Gustave Roussy Dept Hematol F-94805 Villejuif France|Paris Saclay Univ INSERM Unit 1170 Gustave Roussy Canc Campus Villejuif France;
Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France;
Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France;
Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France;
Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France;
Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France;
Paris Saclay Univ Pharm Clin Serv Gustave Roussy Canc Campus Villejuif France;
Univ Paris Saclay Gustave Roussy Dept Hematol F-94805 Villejuif France|Paris Saclay Univ INSERM Unit 1170 Gustave Roussy Canc Campus Villejuif France;
Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France;
Sorbonne Univ Inst Brain & Spinal Cord Univ Hosp Pitie Salpetriere Charles Foix Dept Neurosurg Neurol Serv 2 Mazarin Paris France|Harvard Med Sch Dana Farber Canc Inst Dept Oncol Pathol Boston MA 02115 USA;
机译:与IDH1突变的胶质母细胞瘤相比,IDH1野生型间变性星形细胞瘤的患者预后较差,IDH1突变状态说明了较高年龄的不良预后效应:对神经胶质瘤分类的影响。
机译:与IDH1突变的胶质母细胞瘤相比,IDH1野生型间变性星形细胞瘤的患者预后较差,IDH1突变状态说明了较高年龄的不良预后效应:对神经胶质瘤分类的影响
机译:IDH1基因突变状态与复发性神经胶质瘤患者生存率的相关性。
机译:胶质瘤患者的MGMT和IDH1联合状态预测的多标签感应矩阵完成
机译:使用小说深入学习网络预测胶质瘤患者的异偶酯脱氢酶1(IDH1)突变
机译:IDH1 / 2-突变反复性胶质瘤患者的5-氮己啶
机译:ACTR-46。 AG120,一种复发性或渐进式IDH1突变胶质瘤患者的一类突变体IDH1抑制剂:1型胶质瘤扩张队列的结果